IP20: THE PATIENT PERSPECTIVE AND VALUE ASSESSMENT: EASY TO IDENTIFY THE NEED, HARD TO AGREE ON THE SOLUTION

1:45 PM to 2:45 PM on Wednesday, May 23, 2018

W20: FIXING THE TOWER OF BABEL: ESTABLISHING A COMMON METRIC FOR PATIENT-REPORTED OUTCOME MEASURES

1:45 PM to 2:45 PM on Wednesday, May 23, 2018

IP21: IS ARTIFICIAL INTELLIGENCE THE NEXT BIG THING IN HEALTHCARE DECISION MAKING?

1:45 PM to 2:45 PM on Wednesday, May 23, 2018

W21: PRINCIPLES OF EFFECTIVE MACHINE LEARNING APPLICATIONS IN REAL WORLD EVIDENCE

1:45 PM to 2:45 PM on Wednesday, May 23, 2018

BREAK

2:45 PM to 3:00 PM on Wednesday, May 23, 2018

BREAK

2:45 PM to 3:00 PM on Wednesday, May 23, 2018

BREAKOUT SESSION

3:00 PM to 4:00 PM on Wednesday, May 23, 2018

P16: INFECTIOUS DISEASE AND RESPIRATORY STUDIES

3:00 PM to 4:00 PM on Wednesday, May 23, 2018

P17: NEUROLOGICAL CONDITIONS STUDIES

3:00 PM to 4:00 PM on Wednesday, May 23, 2018

IP22: CHALLENGES AND OPPORTUNITIES IN THE USE OF REAL-WORLD EVIDENCE FOR REGULATORY DECISION MAKING FOR IN VITRO DIAGNOSTICS

3:00 PM to 4:00 PM on Wednesday, May 23, 2018

W22: THE MEDIUM IS THE MESSAGE: USING INTERACTIVE GRAPHICS TO EFFECTIVELY COMMUNICATE HEALTH ECONOMICS AND OUTCOMES RESEARCH FINDINGS

3:00 PM to 4:00 PM on Wednesday, May 23, 2018

IP23: ESTIMATING SAMPLE SIZE FOR QUALITATIVE RESEARCH IN CLINICAL OUTCOME ASSESSMENT RESEARCH: ONE SIZE DOES NOT FIT ALL!

3:00 PM to 4:00 PM on Wednesday, May 23, 2018

W23: ESTIMATING THE COST OF ADVERSE EVENTS IN ECONOMIC MODELS: A DISCUSSION OF REAL-WORLD DATA VERSUS TREATMENT GUIDELINES BASED METHODOLOGIES

3:00 PM to 4:00 PM on Wednesday, May 23, 2018